EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Newcastle Disease Virus Induces Pyroptosis in Canine Mammary Tumour CMT ‐ U27 Cells via the TNFα / NF ‐ κB / NLRP3 Signalling Pathway

Mengqing Li, Yunjie Zhu, Meng Li

Veterinary and Comparative Oncology · 2025-06 · 23 (2) · 224-235

DOI: 10.1111/vco.13048 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Mammary tumours are the most common type of neoplasm in female dogs, with nearly half being malignant. Oncolytic Newcastle disease virus (NDV) therapy has emerged as a novel cancer treatment option; however, its precise oncolytic mechanism in canine mammary tumours (CMT) remain unclear. Ultrastructural analysis of NDV‐infected CMT‐U27 cells with locally damaged cell membranes and swollen and ruptured mitochondria revealed the occurrence of pyroptosis. Transcriptome sequencing further identified a significant upregulation of pyroptosis‐related genes, including NLRP1, NOD2, caspase‐1, and GSDMD. Subsequent examination of RNA and protein expression levels of pyroptosis‐related molecules in vitro indicated that NDV induces pyroptosis in CMT‐U27 cells via the caspase‐1/GSDMD pathway. Additionally, inhibition of the TNFα/NF‐κB pathway and knockdown of NOD‐like receptor pyrin domain‐containing protein 3 (NLRP3) using small interfering RNA demonstrated that the TNFα/NF‐κB pathway can regulate NDV‐induced pyroptosis through the NLRP3 inflammasome. In a xenograft model, intravenous administration of NDV significantly inhibited tumour growth, and prolonged the survival time in nude mice bearing CMT‐U27 cells. NDV treatment enhances intratumoural pyrotosis in tumour bearing mice. In conclusion, these findings suggest that NDV induces pyroptosis in CMT‐U27 cells through the TNFα/NF‐κB/NLRP3 pathway, providing a foundation for future research into NDV's therapeutic potential in canine mammary cancer.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →